coronavirus.The partnership with the German firm will allow the UK to “swiftly tweak and roll out” existing vaccines to combat new variants, according to Business Secretary Kwasi Kwarteng.Almost all vaccines developed through the agreement will be modifications of an existing jab by CureVac, which is currently undergoing phase three clinical trials.The Department for Business, Energy and Industrial Strategy (BEIS) said it will allow large-scale manufacturing in the UK to ramp up quickly to ensure new jabs can be rolled out, if a new strain shows resistance to existing vaccines.Get the latest updates from across Greater Manchester direct to your inbox with the free MEN newsletterYou can sign up very simply by following the instructions.